get a key
steadybase-$ company HBIO
account_id none on file
legal_name Harvard Bioscience Inc
ticker HBIO
cik 1123494
domain harvardbioscience.com
entry_point_account_id none on file
name Harvard Bioscience Inc.
exchange Nasdaq
sector Industrials
hq Holliston, MA, United States
calls 1 filings 0 executives 9 family 0
why_nownone on file
calls
In spite of lower expected revenue, we expect 2024 full year gross margin of approximately 59 to 60%, reflecting our continued focus on expense management.

Aug 8, 2024 / receipt, needs a key / Jim, other | earnings call 2024-08-08 | transcript fca45942-a3e3-4e90-9e54-e1fdb411e74c | chars 14830-14985 | segment 15

filingsnone on file
executives
David Green Interim Chief Executive Officer - receipt
James Green President and Chief Executive Officer - receipt
Jeffrey Duchemin Chief Executive Officer - receipt
Jennifer Cody CFO - receipt
Jim Green CEO - receipt
John Duke President & Chief Executive Officer - receipt
Mark Frost Interim Chief Financial Officer linkedin receipt
Michael Rossi Chief Financial Officer - receipt
Yash Singh Executive Vice President - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled webcast / ir
changes
2026-03-10 Chief Financial Officer, appointed sec_8k
2025-07-17 President and Chief Executive Officer, appointed sec_8k
2025-04-10 Chief Financial Officer, departed sec_8k
2025-04-10 Interim Chief Financial Officer, appointed sec_8k
2022-12-12 Interim Chief Financial Officer, appointed sec_8k
2019-11-01 Executive Vice President, appointed sec_8k
2019-07-19 Chief Financial Officer, appointed sec_8k
2019-07-08 President and Chief Executive Officer, appointed sec_8k
2013-08-29 Chief Executive Officer, appointed sec_8k
2013-05-16 Chief Executive Officer, retiring sec_8k
2013-05-16 Interim Chief Executive Officer, appointed sec_8k
2008-04-25 Chief Financial Officer, departed sec_8k
mcp_package_hint
steadybase-$